To summarize, DRE is a valuable tool alongside PSA for prostate cancer investigation, however, an abnormal DRE performed in primary care with normal PSA is less likely to indicate prostate cancer than with a raised PSA. This evidence concerns the gene KLK3 and prostate carcinoma.